Shaun Curtis
Known title: SVP, Global Manuf./Sup. ChainCIK: 0001920125
Associated companies
Transaction History
| EMBC | ▼ Sell | Tax Withholding | 15,380 | $193K | 11/26/2025 | View on chart |
| EMBC | ▲ Buy | Grant | 37,789 | $0 | 11/26/2025 | View on chart |
| EMBC | ▲ Buy | Grant | 11,305 | $0 | 11/26/2025 | View on chart |
| EMBC | ▼ Sell | Tax Withholding | 3,249 | $39K | 4/4/2025 | View on chart |
| EMBC | ▲ Buy | Grant | 24,065 | $0 | 11/26/2024 | View on chart |
| EMBC | ▼ Sell | Tax Withholding | 5,806 | $109K | 11/26/2024 | View on chart |
| EMBC | ▲ Buy | Grant | 18,583 | $0 | 11/26/2023 | View on chart |
| EMBC | ▼ Sell | Tax Withholding | 4,351 | $76K | 11/26/2023 | View on chart |
| EMBC | ▼ Sell | Tax Withholding | 920 | $25K | 1/27/2023 | View on chart |
| EMBC | ▲ Buy | Grant | 9,080 | $0 | 11/26/2022 | View on chart |
| EMBC | ▼ Sell | Tax Withholding | 2,191 | $72K | 11/26/2022 | View on chart |
| EMBC | ▲ Buy | Grant | 5,699 | $0 | 4/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Concentra Group Hits 52-Week High Amid Medical Services Trends
Concentra Group Holdings, the parent company of Embecta, recently reached a 52-week high, prompting questions about the sustainability of this price movement. This development is relevant to Embecta shareholders as it reflects broader sentiment in the medical services sector. Embecta itself trades with a low trailing P/E of 3.7 and offers a dividend yield of 3.43%, while its stock remains significantly below its 52-week high of $14.91.
Concentra Group Hits 52-Week High Amid Medical Services Trends. Concentra Group Holdings, the parent company of Embecta, recently reached a 52-week high, prompting questions about the sustainability of this price movement. This development is relevant to Embecta shareholders as it reflects broader sentiment in the medical services sector. Embecta itself trades with a low trailing P/E of 3.7 and offers a dividend yield of 3.43%, while its stock remains significantly below its 52-week high of $14.91.